Source link : https://www.newshealth.biz/health-news/pro-urokinase-a-less-expensive-thrombolytic-for-stroke/
ABU DHABI, UAE — Thrombolytic treatment with recombinant human pro-urokinase was non-inferior to alteplase in achieving an excellent functional outcome in acute ischemic stroke but showed a significantly lower rate of intracerebral hemorrhage, new phase 3 trial results showed. This finding supports the use of recombinant human pro-urokinase as a potential alternative to alteplase for […]
Author : News Health
Publish date : 2024-10-30 13:15:15
Copyright for syndicated content belongs to the linked Source.